What are the side effects of PEG-MGF?
The most commonly reported PEG-MGF side effects are hypoglycemia at higher doses, localized growth at injection site, headache. Most are mild and tend to be dose dependent. It is generally avoided with active malignancy. Human clinical evidence for PEG-MGF is limited, so this reflects reported and observed effects, not a complete safety profile.
Reported PEG-MGF side effects
- Hypoglycemia at higher doses
- Localized growth at injection site
- Headache
- Theoretical: cardiac and other tissue growth at chronic high dose
Who should avoid it
- Active malignancy
- Diabetic retinopathy
- Pregnancy / nursing
Bloodwork worth tracking
- IGF-1 baseline + at week 4
- Fasting glucose every 2 weeks
References
- Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation — Yang SY & Goldspink G, FEBS Letters, 2002
- Mechano-Growth Factor: an important cog or a loose screw in the repair machinery? — Zabłocka B, Goldspink PH, Goldspink G, Górecki DC, Frontiers in Endocrinology, 2012
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on PEG-MGF
Last updated 2026-06-06.